安达卢西亚2022-2024年成人4型侵袭性肺炎球菌病危险因素与疫苗覆盖优化
该研究基于西班牙安达卢西亚2022至2024年监测系统数据,分析1359例侵袭性肺炎球菌病(IPD)患者,比较4型与其他血清型的分布特征。多因素分析显示,男性、15-64岁、未接种肺炎球菌疫苗、肺炎表现及精神活性药物使用史与4型IPD风险升高相关。作者建议调整并强化本地疫苗接种策略以预防IPD。
要点
- 4型IPD在15-64岁成人中风险显著高于65岁以上人群
- 未接种肺炎球菌疫苗者4型IPD风险约为已接种者的3.77倍
- 男性、肺炎表现及精神活性药物使用史与4型IPD风险升高相关
核心结论
- 年轻年龄、男性、未接种肺炎球菌疫苗、不良习惯及肺炎表现与新兴4型IPD相关,公共卫生策略应调整并强化本地疫苗接种规划。
研究设计与样本
- 观察性纵向研究纳入2022至2024年安达卢西亚流行病学监测系统报告的实验室确诊IPD病例,排除血清型数据缺失者,最终分析1359例。
主要发现
- 最常见血清型为8型(20.1%)、3型(17.1%)和4型(10.6%)。
- 与65岁及以上人群相比,45-64岁(OR=3.58,95%CI:2.22-5.97)和15-44岁(OR=3.34,95%CI:1.92-5.91)的4型IPD风险更高。
- 男性(OR=2.36,95%CI:1.54-3.71)、未接种肺炎球菌疫苗(OR=3.77,95%CI:2.15-7.07)、肺炎表现(OR=3.08,95%CI:2.03-4.80)及精神活性药物使用史(OR=2.50,95%CI:1.04-5.77)与4型IPD风险升高相关。
临床怎么用
- 在成人IPD防控中应关注15-64岁人群及未接种肺炎球菌疫苗者,结合本地血清型分布评估和调整结合疫苗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Spain in 2023, most reported cases of invasive pneumococcal disease (IPD) were caused by serotypes 8, 3, 22F, and 4. Almost 70.0% of serotype 4 cases were notified in Andalusia (southern Spain). Our aim was to characterize socio-demographic and clinical factors associated with serotype 4 versus other serotypes, and to describe theoretical coverage of currently approved vaccines. METHODS: We conducted an observational longitudinal study including individuals with confirmed invasive pneumococcal disease (IPD) reported to the Andalusian Epidemiological Surveillance System from 2022, to 2024. Cases with unavailable pneumococcal serotype data were excluded. Descriptive analyses and multivariable logistic regression were performed to assess the characteristics of IPD cases according to serotype (serotype 4 vs. other serotypes), using R software. RESULTS: A total of 1359 IPD patients were analysed. The 3 most frequent serotypes reported were 8 (20.1%), 3 (17.1%), 4 (10.6%). Factors associated with increased odds of serotype 4 were male sex (OR = 2.36, 95%CI: 1.54-3.71); age groups of 45-64 years (OR = 3.58, 95%CI: 2.22-5.97) and 15-44 years (OR = 3.34, 95%CI: 1.92-5.91) compared to age group ≥65 years old; no previous pneumococcal vaccination (OR = 3.77, 95%CI: 2.15-7.07) and pneumonia (OR = 3.08, 95%CI: 2.03-4.80). History of psychoactive drug use (OR = 2.50, 95%CI: 1.04-5.77) was associated with serotype 4. CONCLUSIONS: Social and demographic factors such as younger age, male sex, location, no previous pneumococcal vaccination, toxic habits and pneumonia as clinical form, were associated with emerging serotype 4 IPD. Public health strategies should adapt and reinforce local vaccination programs to prevent and reduce IPD.
引用
- Marín-Caba E, Lorusso N, Sempere J, et al. Young adults at risk of emerging serotype 4 invasive pneumococcal disease vs. other serotypes in Andalusia (Spain), 2022 to 2024: optimising conjugated vaccines strategies. Vaccine. 2026. PMID: 42241836. doi:10.1016/j.vaccine.2026.128790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。